Weigelt Annika, Akhundova Gunay, Raming Roman, Tratzky Jan-Philipp, Regensburger Adrian P, Kraus Calvin, Waellisch Wolfgang, Trollmann Regina, Woelfle Joachim, Dittrich Sven, Heiss Rafael, Knieling Ferdinand, Schoeffl Isabelle
Department of Pediatric Cardiology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Loschgestrasse 15, 91054, Erlangen, Germany.
Department of Pediatrics, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Loschgestrasse 15, 91054, Erlangen, Germany.
Eur J Pediatr. 2025 Jun 10;184(7):413. doi: 10.1007/s00431-025-06245-y.
Few studies have examined post-COVID-19 sequelae in children, particularly regarding cardiopulmonary capacity. Longitudinal data are especially scarce. This study aimed to retest pediatric patients previously assessed in a cross-sectional design. In this longitudinal study, children meeting post-COVID-19 criteria and an age- and sex-matched control group underwent cardiopulmonary exercise testing at baseline and after 6 months. Thirteen of 20 post-COVID-19 children (mean age: 13.6 ± 2.6 years, 48% female) and 23 of 28 controls (mean age: 11.9 ± 3.1 years, 62% female) completed follow-up testing. All participants completed a maximal treadmill test. No significant differences were found in peak oxygen uptake ( 39.5 ± 11.0 ml/kg/min vs. 45.5 ± 8.4 ml/kg/min; p = 0.101). Over 6 months, cardiopulmonary performance improved significantly across all subjects. Subgroup analysis showed improvements in both groups, although changes were not statistically significant. Oxygen pulse also proved to be significantly higher and the half-time recovery of proved to be significantly longer after 6 months which was true for the overall group but not for the subgroups.
This is the first longitudinal study to reassess cardiopulmonary capacity in children with post-COVID-19. The initially reduced normalized, and all children showed improved cardiopulmonary capacity after 6 months. The primary improvement was observed in the O pulse, a surrogate marker of stroke volume and, by extension, cardiac output. This finding suggests an enhancement in cardiovascular performance, reflecting improved central hemodynamic in all children 6 months after the pandemic. Deconditioning thus remains a plausible cause for the post-COVID-19 symptoms.
ClinicalTrials.gov Identifier: NCT05445531.
• Children with post-COVID-19 (PASC) may exhibit reduced cardiopulmonary function (V̇O2 peak). Fatigue and exercise intolerance are common but poorly understood and objectified. • Previous studies have provided valuable cross-sectional insights but have yet to include longitudinal follow-up data.
• First longitudinal CPET-based study reassessing children with PASC after 6 months. • Cardiopulmonary performance, including V̇O2 peak and O2 pulse, improved significantly over time, probably due to reversible deconditioning rather than organ damage.
很少有研究调查新冠病毒感染后儿童的后遗症,尤其是心肺功能方面。纵向数据尤为匮乏。本研究旨在对先前采用横断面设计评估过的儿科患者进行重新测试。在这项纵向研究中,符合新冠病毒感染后标准的儿童以及年龄和性别匹配的对照组在基线时和6个月后接受了心肺运动测试。20名新冠病毒感染后儿童中有13名(平均年龄:13.6±2.6岁,48%为女性)和28名对照组儿童中有23名(平均年龄:11.9±3.1岁,62%为女性)完成了随访测试。所有参与者都完成了最大跑步机测试。在峰值摄氧量方面未发现显著差异(39.5±11.0毫升/千克/分钟对45.5±8.4毫升/千克/分钟;p=0.101)。在6个月的时间里,所有受试者的心肺功能均有显著改善。亚组分析显示两组均有改善,尽管变化无统计学意义。氧脉搏在6个月后也被证明显著更高,而的半衰期恢复在6个月后被证明显著更长,这在总体组中是如此,但在亚组中并非如此。
这是第一项重新评估新冠病毒感染后儿童心肺功能的纵向研究。最初降低的恢复正常,所有儿童在6个月后心肺功能均有改善。主要改善体现在氧脉搏上,氧脉搏是每搏输出量的替代指标,进而也是心输出量的替代指标。这一发现表明心血管功能有所增强,反映出疫情爆发6个月后所有儿童的中心血流动力学得到改善。因此,身体机能下降仍然是新冠病毒感染后症状的一个合理原因。
ClinicalTrials.gov标识符:NCT05445531。
• 新冠病毒感染后儿童(PASC)可能表现出心肺功能下降(峰值摄氧量)。疲劳和运动不耐受很常见,但了解和客观化程度较低。• 先前的研究提供了有价值的横断面见解,但尚未包括纵向随访数据。
• 第一项基于心肺运动试验的纵向研究,在6个月后重新评估新冠病毒感染后儿童。• 心肺功能,包括峰值摄氧量和氧脉搏,随时间显著改善,可能是由于可逆的身体机能下降而非器官损伤。